Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alfentanil versus dexmedetomidine for awake fiberoptic intubation
IRCT20141202020185N2Phase 2Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, double-blind trial of alfentanil and dexmedetomidine (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Control of patient agitation, Hemodynamic stability and 1 more. Started Apr 2020; status: completed.
02
Drugs
alfentanildexmedetomidine
Beyond the preview
Go deeper on IRCT20141202020185N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20141202020185N2.